drugset / Trial / NCT02101229

Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital

NCT02101229

RandomizedCrossoverOpen-labelHealth-services research

Summary

To assess whether the DIABELOOP algorithm provides better glycemic control than the usual algorithm of T1D patients on pump therapy: * at meals, with CHO roughly assessed by the patient. * during and after physical activity sessions qualified as moderate by the patient. Primary endpoint : time within the glycemic reference range. The study will be conduct with 15 patients at the following investigation centers : Corbeil Hospital, CHU of Grenoble, and CHU of Montpellier.

Timeline

Start
2014-05
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic